Austar Lifesciences (HKSE:06118) Other Long-Term Liabilities : HK$48 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Austar Lifesciences Other Long-Term Liabilities?

Austar Lifesciences's other long-term liabilities for the quarter that ended in Dec. 2024 was HK$48 Mil.

Austar Lifesciences's quarterly other long-term liabilities increased from Dec. 2023 (HK$47 Mil) to Jun. 2024 (HK$48 Mil) and increased from Jun. 2024 (HK$48 Mil) to Dec. 2024 (HK$48 Mil).

Austar Lifesciences's annual other long-term liabilities declined from Dec. 2022 (HK$47 Mil) to Dec. 2023 (HK$47 Mil) but then increased from Dec. 2023 (HK$47 Mil) to Dec. 2024 (HK$48 Mil).

Austar Lifesciences Other Long-Term Liabilities Historical Data

The historical data trend for Austar Lifesciences's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Austar Lifesciences Other Long-Term Liabilities Chart

Austar Lifesciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

19.26

37.96

47.43

46.84

48.20

Austar Lifesciences Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Long-Term Liabilities	Get a 7-Day Free Trial															47.43	47.87	46.84	47.60	48.20

Austar Lifesciences Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Austar Lifesciences Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Austar Lifesciences's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Austar Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Austar Lifesciences Ltd (HKSE:06118) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1018 Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN

Website

https://www.austar.com.hk

Austar Lifesciences Ltd is engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipments and consumables in the People's Republic of China. The company's segments include Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC). Geographically, it derives the majority of its revenue from Mainland China.

Executives

True Worth Global Limited	2101 Beneficial owner
Cheung Chau Ping	2202 Interest of your spouse
Ho Kin Hung	2201 Interest of corporation controlled by you

Austar Lifesciences Headlines

No Headlines